HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Improving Shared Decision-Making in Menstrual Management and Contraception for Adolescents and Young Adults: A Cluster-Randomized Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Decision aids are educational tools designed to help people participate in decision-making about health care choices, by providing evidence-based information, promoting patient-centered care, and supporting patient autonomy and engagement. Our research team developed an Encounter Decision Aid (EDA) exploring treatment options for menstrual management in adolescents and young adults (AYAs), in accordance with the latest International Patient Decision Aids Standards and the Ottawa Decision Support Framework. In this cluster-randomized controlled trial, we aim to evaluate the effectiveness of this EDA on patient-centered outcome measures in AYAs considering treatment for menstrual management and/or contraception compared to standard counseling.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 12
Maximum Age: 25
Healthy Volunteers: f
View:

• adolescents and young adults aged 12-25 years old

• presenting to an outpatient consultation at Unité de policlinique de gynécologie or Consultation de gynécologie pédiatrique at HUG

• considering initiation or switch to hormonal medication for menstrual management and/or contraception

• able to give informed consent as documented by signature or accompanied by a legal guardian who can provide consent if required.

Locations
Other Locations
Switzerland
Geneva University Hospitals
RECRUITING
Geneva
Contact Information
Primary
Dehlia Moussaoui
dehlia.moussaoui@hug.ch
+41 22 372 33 87
Time Frame
Start Date: 2025-09-02
Estimated Completion Date: 2028-01
Participants
Target number of participants: 252
Treatments
Active_comparator: control group
Experimental: intervention group
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Geneva

This content was sourced from clinicaltrials.gov